The skin microbiome of caspase-14-deficient mice shows mild dysbiosis.
2014Experimental dermatology
Disease-relevant preclinical or model-based paper useful as supporting evidence.
Investigation of the skin microbiome: swabs vs. biopsies.
2019The British journal of dermatology
Disease-relevant preclinical or model-based paper useful as supporting evidence.
Psychosocial Impact of Atopic Dermatitis in Adults: A Qualitative Study.
2020Actas dermo-sifiliograficas
Disease-relevant preclinical or model-based paper useful as supporting evidence.
Comparing DADA2 and OTU clustering approaches in studying the bacterial communities of atopic dermatitis.
2020Journal of medical microbiology
Disease-relevant preclinical or model-based paper useful as supporting evidence.
[Probiotic baths for atopic dermatitis].
2021Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete
Disease-relevant preclinical or model-based paper useful as supporting evidence.
Description and comparison of the skin and ear canal microbiota of non-allergic and allergic German shepherd dogs using next generation sequencing.
2021PloS one
Disease-relevant preclinical or model-based paper useful as supporting evidence.
Microbial dysbiosis in a mouse model of atopic dermatitis mimics shifts in human microbiome and correlates with the key pro-inflammatory cytokines IL-4, IL-33 and TSLP.
2022Journal of the European Academy of Dermatology and Venereology : JEADV
Disease-relevant preclinical or model-based paper useful as supporting evidence.
The Skin and Nose Microbiome and Its Association with Filaggrin Gene Mutations in Pediatric Atopic Dermatitis.
2022Dermatology (Basel, Switzerland)
Disease-relevant preclinical or model-based paper useful as supporting evidence.
Exploring the Differences in the Gut Microbiome in Atopic Dermatitis According to the Presence of Gastrointestinal Symptoms.
2022Journal of clinical medicine
Disease-relevant preclinical or model-based paper useful as supporting evidence.
Altered Maturation of the Skin Microbiome in Infants with Atopic Dermatitis.
2022Acta dermato-venereologica
Disease-relevant preclinical or model-based paper useful as supporting evidence.
Skin microbiome and its association with host cofactors in determining atopic dermatitis severity.
2023Journal of the European Academy of Dermatology and Venereology : JEADV
Disease-relevant preclinical or model-based paper useful as supporting evidence.
Cutaneous dysbiosis may amplify barrier dysfunction in patients with atopic dermatitis.
2022Frontiers in microbiology
Disease-relevant preclinical or model-based paper useful as supporting evidence.
Increased risk of osteoarthritis in patients with atopic disease.
2023Annals of the rheumatic diseases
Disease-relevant preclinical or model-based paper useful as supporting evidence.
A simplified bacterial community found within the epidermis than at the epidermal surface of atopic dermatitis patients and healthy controls.
2023BMC microbiology
Disease-relevant preclinical or model-based paper useful as supporting evidence.
Pinewood VOC emissions protect from oxazolone-induced inflammation and dysbiosis in a mouse model of atopic dermatitis.
2024Environment international
Disease-relevant preclinical or model-based paper useful as supporting evidence.
Effects on the Skin Microbiome by a Moisturizer Formulated for Eczema-Prone and Sensitive Skin.
2025Journal of drugs in dermatology : JDD
Disease-relevant preclinical or model-based paper useful as supporting evidence.
Resilience of the Skin Microbiome in Atopic Dermatitis During Short-Term Topical Treatment.
2025International journal of molecular sciences
Disease-relevant preclinical or model-based paper useful as supporting evidence.
Facial Skin Mycobiome in Atopic Dermatitis With and Without Facial Involvement and Healthy Controls: A Case-Control Study.
2026Experimental dermatology
Disease-relevant preclinical or model-based paper useful as supporting evidence.
Preliminary Characterization of Skin Microbiota and Mycobiota in Atopic Dermatitis by Metagenomic and Culture-Based Analyses.
2026Life (Basel, Switzerland)
Disease-relevant preclinical or model-based paper useful as supporting evidence.